- Saudi Arabia
- /
- Building
- /
- SASE:4145
Al Obeikan Glass (TADAWUL:9531) Has Some Way To Go To Become A Multi-Bagger
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Having said that, from a first glance at Al Obeikan Glass (TADAWUL:9531) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.
What Is Return On Capital Employed (ROCE)?
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Al Obeikan Glass:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.058 = ر.س38m ÷ (ر.س767m - ر.س122m) (Based on the trailing twelve months to September 2024).
Therefore, Al Obeikan Glass has an ROCE of 5.8%. In absolute terms, that's a low return and it also under-performs the Building industry average of 10%.
See our latest analysis for Al Obeikan Glass
Historical performance is a great place to start when researching a stock so above you can see the gauge for Al Obeikan Glass' ROCE against it's prior returns. If you want to delve into the historical earnings , check out these free graphs detailing revenue and cash flow performance of Al Obeikan Glass.
What The Trend Of ROCE Can Tell Us
The returns on capital haven't changed much for Al Obeikan Glass in recent years. Over the past four years, ROCE has remained relatively flat at around 5.8% and the business has deployed 38% more capital into its operations. This poor ROCE doesn't inspire confidence right now, and with the increase in capital employed, it's evident that the business isn't deploying the funds into high return investments.

What We Can Learn From Al Obeikan Glass' ROCE
In summary, Al Obeikan Glass has simply been reinvesting capital and generating the same low rate of return as before. And investors appear hesitant that the trends will pick up because the stock has fallen 51% in the last three years. Therefore based on the analysis done in this article, we don't think Al Obeikan Glass has the makings of a multi-bagger.
On a final note, we found 5 warning signs for Al Obeikan Glass (3 make us uncomfortable) you should be aware of.
While Al Obeikan Glass isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SASE:4145
Al Obeikan Glass
Engages in wholesale and retail sale of chemicals and glass panels in Saudi Arabia and internationally.
Excellent balance sheet and slightly overvalued.
Market Insights
Weekly Picks

This small biotech is developing technology that could potentially change how tissue is rebuilt

The Picks-and-Shovels Leader of the Grid Supercycle
KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Invinity Energy Systems: All About That BESS
Recently Updated Narratives
A Bet on the Last Breath of a Flying Prototype

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Roblox Future PE to Soar by 17% in the Next 5 Years
Popular Narratives

Investment Analysis (May 2026)

Honeywell - The Demand-Side of the AI Infrastructure

